Acne Scarring. Acne vulgaris
Conditions
Interventions
Intervention 1: Injection of SVF gel extracted from the patient’s own fat using the Vira cell company-manufactured kit, according to protocol, into the scar area combined with subcision in a single se
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age upper than 18 age lower than 50 BMI upper than 27 Having Acne scarring
Exclusion criteria
Exclusion criteria: family history of bleeding or coagulopathies use of anticoagulant or steroid medications hemoglobin levels below 10 g/dL platelet counts below 150,000/µL active skin or systemic infections malignancy or a history of chemotherapy lactation pregnancy use of any analgesic medications within one week prior to the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Derm thickness. Timepoint: 1 month and 3 month later. Method of measurement: Visioface device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Sameni
Tehran University of Medical Sciences
Outcome results
None listed